A Stablon, Coaxil, Tatinol, Tianeptine sodium salt CEP of the European Pharmacopoeia monograph is often referred to as a Stablon, Coaxil, Tatinol, Tianeptine sodium salt Certificate of Suitability (COS). The purpose of a Stablon, Coaxil, Tatinol, Tianeptine sodium salt CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Stablon, Coaxil, Tatinol, Tianeptine sodium salt EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Stablon, Coaxil, Tatinol, Tianeptine sodium salt to their clients by showing that a Stablon, Coaxil, Tatinol, Tianeptine sodium salt CEP has been issued for it. The manufacturer submits a Stablon, Coaxil, Tatinol, Tianeptine sodium salt CEP (COS) as part of the market authorization procedure, and it takes on the role of a Stablon, Coaxil, Tatinol, Tianeptine sodium salt CEP holder for the record. Additionally, the data presented in the Stablon, Coaxil, Tatinol, Tianeptine sodium salt CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Stablon, Coaxil, Tatinol, Tianeptine sodium salt DMF.
A Stablon, Coaxil, Tatinol, Tianeptine sodium salt CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Stablon, Coaxil, Tatinol, Tianeptine sodium salt CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Stablon, Coaxil, Tatinol, Tianeptine sodium salt suppliers with CEP (COS) on PharmaCompass.